According to GLOBOCAN 2022, breast cancer is the most common type of cancer in Vietnam, with 24,563 new cases, accounting for 28.9% of women's cancer cases, causing more than 10,000 deaths, accounting for 8.3% of all deaths from cancer. breast cancer with herner2 positive type accounts for 20% of is a type of cancer that tends to be more malignant.
Despite many advances in treatment, the patient still faces many challenges such as resistance to herbal anti2.2, leading to reduced treatment effectiveness and high treatment costs. Early detection and early access to biological therapies are important factors that help patients have the opportunity to treat effectively and save treatment costs.
Sharing a global perspective on similar biological drugs at the conference, Dr. Paul Cornes - Clinical Cancer Consultant - Comparative Outcomes Group, said: "A similar biological drug that is truly valuable needs to meet two requirements. First, there must be a treatment effect equivalent to the original drug. Second, we must help reduce costs for patients, the health system and the parties to pay, thereby bringing economic benefits".
Associate Professor. Dr. DS. Nguyen Tuan Dung said: The emergence of similar biological drugs contributes to reducing treatment costs, increasing patients' access to effective treatment, and prolonging life. Currently, the demand for similar biological drugs in Vietnam is increasing."
